The Hindu : Business : Bse/Nse Notes

Online edition of India's National Newspaper
Wednesday, Mar 29, 2006

Business

Business

Bse/Nse Notes

The following are among the information furnished to the Bombay Stock Exchange and the National Stock Exchange by the companies concerned.

Ind Swift Laboratories has received the certification from the European Directorate for the Quality of Medicines for its key bulk drug Clarithromycin. This is the second significant certification which the company has received within a short span of time.

Gujarat NRE Coke has announced the launch of $ 50 million unsubordinated unsecured foreign currency convertible bonds (FCCBs) due 2011. In addition there is an option to increase the issue size by an additional $ 10 million. These will be convertible into ordinary shares of the company, quoted in Indian rupees. The bonds have a tenor of five years and one day and are expected to carry a coupon of 0 per cent with a yield to maturity of 6.50 per cent to 7 per cent per annum. The bonds will get converted into equity shares at a price of Rs. 125 per share.

Pfizer has posted a net profit, after taxation, of Rs. 24.77 crore for the quarter ended February 2006 against Rs. 13.46 crore in the same quarter in the previous year. Total Income has increased to Rs. 158.04 crore from Rs. 141.67 crore.

RPG Transmission has bagged an order for Rs. 119 crore from Power Grid Corporation of India for a transmission project funded by the Asian Development Bank.

Western India Shipyard has won a major contract from PMC Projects (India) Pvt. Ltd. for the construction of multi utility craft of the value of about Rs. 3.5 crore, under the India Flag.

IL&FS Investment Managers has said that a meeting of the board of directors will be held on April 4 to consider the issue of bonus shares and raising of fresh capital through issue of securities in the international markets.

Printer friendly page
Send this article to Friends by E-Mail